AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42

Authors: Mandir, AS Dawson, VL Dawson, TM
Citation: As. Mandir et al., Gene therapy to the rescue in Parkinsons's disease, TRENDS PHAR, 22(3), 2001, pp. 103-105

Authors: Chung, KKK Zhang, Y Lim, KL Tanaka, Y Huang, H Gao, J Ross, CA Dawson, VL Dawson, TM
Citation: Kkk. Chung et al., Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1:implications for Lewy-body formation in Parkinson disease, NAT MED, 7(10), 2001, pp. 1144-1150

Authors: Wildemann, B Haas, J Stingele, K Storch-Hagenlocher, B McArthur, JC Dawson, TM Dawson, VL
Citation: B. Wildemann et al., Identification by mRNA differential display of two up-regulated genes as candidate mediators of AIDS dementia, MOL MED, 7(3), 2001, pp. 193-199

Authors: Tanaka, Y Engelender, S Igarashi, S Rao, RK Wanner, T Tanzi, RE Sawa, A Dawson, VL Dawson, TM Ross, CA
Citation: Y. Tanaka et al., Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis, HUM MOL GEN, 10(9), 2001, pp. 919-926

Authors: Guo, X Dawson, VL Dawson, TM
Citation: X. Guo et al., Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons, EUR J NEURO, 13(9), 2001, pp. 1683-1693

Authors: Guo, X Dillman, JF Dawson, VL Dawson, TM
Citation: X. Guo et al., Neuroimmunophilins: Novel neuroprotective and neuroregenerative targets, ANN NEUROL, 50(1), 2001, pp. 6-16

Authors: Dawson, TM Starkebaum, G Wood, BL Willkens, RF Gown, AM
Citation: Tm. Dawson et al., Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoidarthritis and primary Sjogren's syndrome: Case series, J RHEUMATOL, 28(1), 2001, pp. 47-53

Authors: Chung, KKK Dawson, VL Dawson, TM
Citation: Kkk. Chung et al., The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders, TRENDS NEUR, 24(11), 2001, pp. S7-S14

Authors: Nucifora, FC Sasaki, M Peters, MF Huang, H Cooper, JK Yamada, M Takahashi, H Tsuji, S Troncoso, J Dawson, VL Dawson, TM Ross, CA
Citation: Fc. Nucifora et al., Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity, SCIENCE, 291(5512), 2001, pp. 2423-2428

Authors: Aghdasi, B Ye, KQ Resnick, A Huang, A Ha, HC Guo, X Dawson, TM Dawson, VL Snyder, SH
Citation: B. Aghdasi et al., FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle, P NAS US, 98(5), 2001, pp. 2425-2430

Authors: Chiavegatto, S Dawsons, VL Mamounas, LA Koliatsos, VE Dawson, TM Nelson, RJ
Citation: S. Chiavegatto et al., Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase, P NAS US, 98(3), 2001, pp. 1277-1281

Authors: Nandagopal, K Dawson, TM Dawson, VL
Citation: K. Nandagopal et al., Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance, J PHARM EXP, 297(2), 2001, pp. 474-478

Authors: Przedborski, S Dawson, TM
Citation: S. Przedborski et Tm. Dawson, The role of nitric oxide in Parkinson's disease, METH MOL M, 62, 2001, pp. 113-136

Authors: Przedborski, S Vila, M Jackson-Lewis, V Dawson, TM
Citation: S. Przedborski et al., Reply: a new look at the pathogenesis of Parkinson's disease, TRENDS PHAR, 21(5), 2000, pp. 165-165

Authors: Dawson, VL Dawson, TM
Citation: Vl. Dawson et Tm. Dawson, Neuronal ischaemic preconditioning, TRENDS PHAR, 21(11), 2000, pp. 423-424

Authors: Zhang, Y Dawson, VL Dawson, TM
Citation: Y. Zhang et al., Oxidative stress and genetics in the pathogenesis of Parkinson's disease, NEUROBIOL D, 7(4), 2000, pp. 240-250

Authors: Marsh, L Dawson, TM
Citation: L. Marsh et Tm. Dawson, Treatment of early Parkinson's disease, BR MED J, 321(7252), 2000, pp. 1-2

Authors: Dawson, TM
Citation: Tm. Dawson, Parkinson's disease: clinical manifestations and treatment, INT R PSYC, 12(4), 2000, pp. 263-269

Authors: Mandir, AS Poitras, MF Berliner, AR Herring, WJ Guastella, DB Feldman, A Poirier, GG Wang, ZQ Dawson, TM Dawson, VL
Citation: As. Mandir et al., NMDA but not non-NMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase, J NEUROSC, 20(21), 2000, pp. 8005-8011

Authors: Dawson, TM
Citation: Tm. Dawson, New animal models for Parkinson's disease, CELL, 101(2), 2000, pp. 115-118

Authors: Sasaki, M Dawson, TM Dawson, VL
Citation: M. Sasaki et al., Nitric oxide in brain ischemia/reperfusion injury, HANDB EXP P, 143, 2000, pp. 619-637

Authors: Sampei, K Mandir, AS Asano, Y Wong, PC Traystman, RJ Dawson, VL Dawson, TM Hurn, PD
Citation: K. Sampei et al., Stroke outcome in double-mutant antioxidant transgenic mice, STROKE, 31(11), 2000, pp. 2685-2691

Authors: Zhang, Y Gao, J Chung, KKK Huang, H Dawson, VL Dawson, TM
Citation: Y. Zhang et al., Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1, P NAS US, 97(24), 2000, pp. 13354-13359

Authors: Sasaki, M Gonzalez-Zulueta, M Huang, H Herring, WJ Ahn, SY Ginty, DD Dawson, VL Dawson, TM
Citation: M. Sasaki et al., Dynamic regulation of neuronal NO synthase transcription by calcium influxthrough a CREB family transcription factor-dependent mechanism, P NAS US, 97(15), 2000, pp. 8617-8622

Authors: Gonzalez-Zulueta, M Feldman, AB Klesse, LJ Kalb, RG Dillman, JF Parada, LF Dawson, TM Dawson, VL
Citation: M. Gonzalez-zulueta et al., Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning, P NAS US, 97(1), 2000, pp. 436-441
Risultati: 1-25 | 26-42